The global bio-implants market was worth around US$ 92.4 Billion in 2019. Bio-implants are prostheses that are used for replacing, supporting or enhancing a biological structure. They are made up of different biosynthetic materials like collagen and tissue-engineered products like artificial skin. Bio-implants are majorly divided into three categories: biological implants that constitute bioartificial organs, cell therapy and tissue engineering; biologized implants that comprise of in-vivo cell lining, technical implants and biohybrid systems; and biofunctionalized implants that include surface-functionalized implants and drug-eluting stents. Bio-implants have been planted in various spheres of ENT and have resulted in some of the most successful surgical outcomes. They help to regularize physiological functions of patients which allows them to lead an efficient life.
Global Bio-Implants Market Drivers:
The growth of the bio-implants market is driven by a rise in the geriatric population around the world which is the largest end-user of these implants. Moreover, technological advancements and increasing awareness about the success of cosmetic implantations are providing a positive thrust to the market growth. Further, as dental implants are one of the biggest contributors to the growth of the bio-implants market, an increase in dental issues across the globe is aiding the market growth. Additionally, cardiac pacemakers and orthopedic artificial implants are in constant demand owing to the growing prevalence of cardiovascular and orthopedic conditions. Looking forward, IMARC Group expects the global bio-implants market to continue its moderate growth during the next five years.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at